Immunological alterations in lupus-prone autoimmune (NZB/NZW) F1 mice by mycelia Chinese medicinal fungus Cordyceps sinensis-induced redistributions of peripheral mononuclear T lymphocytes.
Mycelia products from wild-form Cordyceps sinensis could be constantly produced in a large scale and would be a better source of this herbal medicine. Our purpose was to investigate the immunological effects of an orally administered hot-water extract cultured mycelium of C. sinensis in lupus-prone (NZB/NZW) F1 hybrids. Forty female mice were divided into four groups and were given 2.4 mg/g/day oral doses of C. sinensis starting at three (group A), six (group B), or eight (group C) months of age, whereas the remaining group (group D) served as a control. Survival, proteinuria, and titers of anti-double-stranded DNA autoantibodies were evaluated. Treatment with C. sinensis resulted in increased survival, decreased proteinuria, and reduced titers of anti-double-stranded DNA antibody in groups A and B. Moreover, the mice in groups A and B showed significantly reduced percentages of CD4(+) T cells (*P < 0.05) and increased percentages of CD8(+) T cells in peripheral blood mononuclear cells (PBMC) after C. sinensis administration. At 6 months of age, the proliferation rate of BrdU-incorporated spleen cells was significantly decreased after 48 and 72 h of C. sinensis treatment (**P < 0.01) in group A of mice. In conclusions, early medication with C. sinensis induced the redistribution of PBMC and attenuated the disease severity of lupus in (NZB/NZW) F1 mice.
Graduate Institute and School of Traditional Chinese Medicine, Chang-Gung University, Center for Traditional Chinese Medicine, Chang-Gung Memorial Hospital, Taoyuan, Taiwan, ROC.
Jiun-Liang
JL
Chen
Yen-Chen
YC
Chen
Sien-Hung
SH
Yang
Yun-Fei
YF
Ko
Shao-Yuan
SY
Chen
D000284:Administration, Oral; D000818:Animals; D000974:Antibodies, Antinuclear / Q000276:immunology; D001323:Autoantibodies / Q000276:immunology; D032661:Cordyceps / Q000276:immunology*; D017931:DNA Primers / Q000737:chemistry; D004365:Drugs, Chinese Herbal / Q000627:therapeutic use*; D005260:Female; D008180:Lupus Erythematosus, Systemic / Q000276:immunology* / Q000473:pathology / Q000517:prevention & control*; D051379:Mice; D008814:Mice, Inbred NZB; D025282:Mycelium / Q000276:immunology*; D011507:Proteinuria; D013154:Spleen / Q000187:drug effects / Q000276:immunology / Q000473:pathology; D015996:Survival Rate; D013601:T-Lymphocytes / Q000276:immunology*
D000974:Antibodies, Antinuclear; D001323:Autoantibodies; D017931:DNA Primers; D004365:Drugs, Chinese Herbal